- Advertisement -

Amino Acid That Delivers “Slow Down” Signal to Brain May Contribute to Major Depression

The results of research headed by scientists at Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology suggest that the amino acid glycine...

New brain research could change how concussions are treated

Credit: Mitra lab/CSHL, 2019 Traumatic brain injuries (TBI), including concussions, can be caused by anything from sports...

Research could help identify disturbances in the body’s copper metabolism

Reviewed by Emily Henderson, B.Sc.May 26 2020 In biology it is well-known that every living organism is triggered by the hereditary material or DNA that...

An international consortium, led by IRB Barcelona and biotechnology company Merus...

Institute for Research in Biomedicine (IRB Barcelona)Barcelona, 25 April 2022- Scientists from an international consortium led by Dr. Eduard Batlle, head of the Colorectal...

Biotechnology advances in controlling mycotoxins – New Food

Mycotoxin control is still considered an issue, especially in developing countries. Here, Navneeta Kaul, member of PreScouter’s global scholar network, reviews biotechnology approaches to...

Penn Medicine appoints Robert Vonderheide to second five-year term as director...

PHILADELPHIA — Robert H. Vonderheide, MD, DPhil, has been appointed to a second five-year term as director of the Abramson Cancer Center (ACC) at the...

Engineered lettuce may turn injectable GLP-1 therapies into oral pills

Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists. Initially approved by the FDA for...

From Discovery to Lot Release: A Validated Suite of Assays for...

Sponsored content brought to you by Potency assays that fail during tech transfer or comparability studies don’t just delay timelines—they erode regulatory confidence and cost...

Engineered lettuce may turn injectable GLP-1 therapies into oral pills

Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists. Initially approved by the FDA for...

From Discovery to Lot Release: A Validated Suite of Assays for Biologics Drug Development

Sponsored content brought to you by Potency assays that fail during tech transfer or comparability studies don’t just delay timelines—they erode regulatory confidence and cost...

Machine learning detects early brain changes linked to Alzheimer’s disease

Worcester Polytechnic Institute (WPI) researchers have used a form of artificial intelligence (AI) to analyze anatomical changes in the brain and predict Alzheimer's disease with...

more new items

Engineered lettuce may turn injectable GLP-1 therapies into oral pills

Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists. Initially approved by the FDA for...

From Discovery to Lot Release: A Validated Suite of Assays for...

Sponsored content brought to you by Potency assays that fail during tech transfer or comparability studies don’t just delay timelines—they erode regulatory confidence and cost...

Machine learning detects early brain changes linked to Alzheimer’s disease

Worcester Polytechnic Institute (WPI) researchers have used a form of artificial intelligence (AI) to analyze anatomical changes in the brain and predict Alzheimer's disease with...